8 completed. 6 Phase 3, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 6 | Completed 6 |
| Phase 2 | 2 | Completed 2 |
Follow Pentacel™: new trials by email Literature Review of Pentacel™ trials Research Report on Pentacel™
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety, Tolerability, and Immunogenicity of V114 in Healthy Infants (V114-029) V114, Prevnar 13™, RotaTeq™ - Pneumococcal Infections, Pneumococcal Vaccines | Phase 3 | Completed | Merck Sharp & Dohme LLC | 1720 | 2019-06-19 | 2023-07-28 |
| A Study to Evaluate the Interchangeability of V114 and Prevnar 13™ in Healthy Infants (V114-027/PNEU-DIRECTION) Prevnar 13™, V114, RotaTeq™ - Pneumococcal Infections | Phase 3 | Completed | Merck Sharp & Dohme LLC | 900 | 2018-10-18 | 2023-01-17 |
| A Study of V419 Given Concomitantly With Prevnar 13™ and RotaTeq™ (V419-006) V419, PENTACEL™, Prevnar 13™ - Bacterial Infections, Virus Diseases | Phase 3 | Completed | Merck Sharp & Dohme LLC | 2808 | 2011-05-10 | 2018-11-15 |
| Safety, Tolerability, and Immunogenicity of V419 Given Concomitantly With Prevnar 13™ and RotaTeq™ (V419-005) V419, DAPTACEL™, PedvaxHIB™ - Bacterial Infections, Virus Diseases | Phase 3 | Completed | Merck Sharp & Dohme LLC | 1473 | 2011-04-19 | 2018-11-15 |
| Consistency & Immunogenicity Study of 3 Lots of GSK's Hib Conjugate Vaccine Versus ActHIB & Pentacel in Healthy Infants GSK Biologicals' Haemophilus influenzae type b vaccine (GSK 208108), ActHIB™, Pentacel™ - Haemophilus Influenzae Type b | Phase 3 | Completed | GlaxoSmithKline | 4003 | 2010-06-18 | 2018-07-12 |
| Study of PR5I, a Pediatric Combination Vaccine With Enhanced Hepatitis B Component Given Concomitantly With Prevnar® Hybrid 5 component DTaP, Vero IPV, Hep B and PRP-OMPC - Diphtheria, Pertussis | Phase 2 | Completed | Sanofi Pasteur, a Sanofi Company | 460 | 2006-08-01 | 2014-01-14 |
| Study of the Effect of Pneumococcal Conjugate Vaccine (PCV) on Immunogenicity of Pentacel™ Pentacel™: HCPDT-IPV//PRP-T Vaccine and Prevnar® - Diphtheria, Tetanus | Phase 3 | Completed | Sanofi | 1167 | 2003-10-01 | 2012-02-01 |
| A Study of the Safety and Tolerability of V419 in Healthy Infants at 2,4, 6 and 12 to 14 Months of Age (V419-003) AR51 (12, 10), PR51 (3, 10), PR51 (6, 10) - Bacterial Infections; Virus Diseases | Phase 2 | Completed | Merck Sharp & Dohme LLC | 756 | 2001-05-01 | 2015-10-30 |
Haemophilus Infections (5) · Diphtheria (4) · Poliomyelitis (4) · Tetanus (4) · Whooping Cough (4) · Bacterial Infections (3) · Hepatitis B (3) · Virus Diseases (3) · Pneumococcal Infections (2) · Gram-Negative Bacterial Infections (1)
Merck Sharp & Dohme LLC (5) · GlaxoSmithKline (1) · Sanofi (1) · Sanofi Pasteur, a Sanofi Company (1)
United States (4) · Puerto Rico (2) · Thailand (2) · Turkey (Türkiye) (2) · Canada (1)
PMID 21134456, PMID 23241989, PMID 24346596, PMID 27846058, PMID 36522265, PMID 36621410, PMID 37846456
2018 (2)